Jasper Bos is a General Partner at Forbion and a Board Member at several organizations, including CellCentric, CatalYm GmbH, ANAVEON AG, and enGene. They previously served as Chief Executive Officer of Forbion European Acquisition Corporation from 2021 to 2023 and held various roles at Merck Serono, culminating in Senior Director of MS Ventures. Jasper earned an MSc and a PhD in pharmacy pharmacoeconomics from the University of Groningen, where they also conducted PhD research. Their extensive experience includes leadership positions on numerous boards in the biotech sector, showcasing a strong background in healthcare and business development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices